{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:26:50Z","timestamp":1794335210041,"version":"4.9.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mater."],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41563-026-02623-5","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:04:05Z","timestamp":1781773445000},"page":"1917-1932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nanotechnology-mediated precision delivery of mRNA"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-8905","authenticated-orcid":false,"given":"Hongzhang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-149X","authenticated-orcid":false,"given":"Zhongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-7479","authenticated-orcid":false,"given":"Yufen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6923-5684","authenticated-orcid":false,"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-1931","authenticated-orcid":false,"given":"Daniel","family":"Siegwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2623_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. mRNA-based cancer therapeutics. Nat. Rev. Cancer 23, 526\u2013543 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2623_CR2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311276120","volume":"120","author":"C Wang","year":"2023","unstructured":"Wang, C., Zhao, C., Wang, W., Liu, X. & Deng, H. Biomimetic noncationic lipid nanoparticles for mRNA delivery. Proc. Natl Acad. Sci. USA 120, e2311276120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR3","doi-asserted-by":"publisher","first-page":"113930","DOI":"10.1016\/j.addr.2021.113930","volume":"177","author":"ML Ibba","year":"2021","unstructured":"Ibba, M. L., Ciccone, G., Esposito, C. L., Catuogno, S. & Giangrande, P. H. Advances in mRNA non-viral delivery approaches. Adv. Drug Deliv. Rev. 177, 113930 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2623_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00425-3","volume":"27","author":"MJ Yuan","year":"2023","unstructured":"Yuan, M. J. et al. mRNA nanodelivery systems: targeting strategies and administration routes. Biomater. Res. 27, 90 (2023).","journal-title":"Biomater. Res."},{"key":"2623_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2623_CR6","doi-asserted-by":"publisher","first-page":"115042","DOI":"10.1016\/j.addr.2023.115042","volume":"200","author":"B Sun","year":"2023","unstructured":"Sun, B. et al. Engineering nanoparticle toolkits for mRNA delivery. Adv. Drug Deliv. Rev. 200, 115042 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2623_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307822","volume":"36","author":"P Huang","year":"2023","unstructured":"Huang, P., Deng, H. Z., Wang, C. R., Zhou, Y. F. & Chen, X. Y. Cellular trafficking of nanotechnology-mediated mRNA delivery. Adv. Mater. 36, e2307822 (2023).","journal-title":"Adv. Mater."},{"key":"2623_CR8","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.1021\/acs.nanolett.4c01709","volume":"24","author":"C Zhao","year":"2024","unstructured":"Zhao, C., Wang, C., Shan, W., Wang, W. & Deng, H. Fusogenic lipid nanovesicle for biomacromolecular delivery. Nano Lett. 24, 8609\u20138618 (2024).","journal-title":"Nano Lett."},{"key":"2623_CR9","doi-asserted-by":"publisher","first-page":"19550","DOI":"10.1021\/acsnano.3c05635","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu, X., Huang, P., Yang, R. & Deng, H. mRNA cancer vaccines: construction and boosting strategies. ACS Nano 17, 19550\u201319580 (2023).","journal-title":"ACS Nano"},{"key":"2623_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207471","volume":"35","author":"P Huang","year":"2023","unstructured":"Huang, P. et al. An integrated polymeric mRNA vaccine without inflammation side effects for cellular immunity mediated cancer therapy. Adv. Mater. 35, 2207471 (2023).","journal-title":"Adv. Mater."},{"key":"2623_CR11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586\u20131600 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2623_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2023","unstructured":"Kim, J., Eygeris, Y., Ryals, R. C., Jozi\u0107, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428\u2013427 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41551-022-00847-9","volume":"6","author":"CD Sago","year":"2022","unstructured":"Sago, C. D. et al. Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver. Nat. Biomed. Eng. 6, 157\u2013167 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR14","doi-asserted-by":"publisher","first-page":"2409812","DOI":"10.1002\/adma.202409812","volume":"36","author":"Y Fei","year":"2024","unstructured":"Fei, Y. et al. Simplified lipid nanoparticles for tissue- and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model. Adv. Mater. 36, 2409812 (2024).","journal-title":"Adv. Mater."},{"key":"2623_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2623_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","volume":"9","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. Precision drug delivery to the central nervous system using engineered nanoparticles. Nat. Rev. Mater. 9, 567\u2013588 (2024).","journal-title":"Nat. Rev. Mater."},{"key":"2623_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01605-4","volume":"20","author":"S Waheed","year":"2022","unstructured":"Waheed, S. et al. Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J. Nanobiotechnol. 20, 395 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"2623_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang, J., Li, Y. & Nie, G. Multifunctional biomolecule nanostructures for cancer therapy. Nat. Rev. Mater. 6, 766\u2013783 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2623_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8, 772\u2013781 (2013).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"2623_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"ZM Zhao","year":"2020","unstructured":"Zhao, Z. M., Ukidve, A., Kim, J. & Mitragotri, S. Targeting strategies for tissue-specific drug delivery. Cell 181, 151\u2013167 (2020).","journal-title":"Cell"},{"key":"2623_CR23","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/cells10102712","volume":"10","author":"JK Hennigs","year":"2021","unstructured":"Hennigs, J. K., Matuszcak, C., Trepel, M. & K\u00f6rbelin, J. Vascular endothelial cells: heterogeneity and targeting approaches. Cells 10, 2712 (2021).","journal-title":"Cells"},{"key":"2623_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41565-020-0759-5","volume":"15","author":"W Poon","year":"2020","unstructured":"Poon, W., Kingston, B. R., Ouyang, B., Ngo, W. & Chan, W. C. W. A framework for designing delivery systems. Nat. Nanotechnol. 15, 819\u2013829 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR25","doi-asserted-by":"publisher","first-page":"2303266","DOI":"10.1002\/adma.202303266","volume":"36","author":"M Hu","year":"2024","unstructured":"Hu, M., Li, X., You, Z., Cai, R. & Chen, C. Physiological barriers and strategies of lipid-based nanoparticles for nucleic acid drug delivery. Adv. Mater. 36, 2303266 (2024).","journal-title":"Adv. Mater."},{"key":"2623_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","volume":"145","author":"G Sahay","year":"2010","unstructured":"Sahay, G., Alakhova, D. Y. & Kabanov, A. V. Endocytosis of nanomedicines. J. Control. Release 145, 182\u2013195 (2010).","journal-title":"J. Control. Release"},{"key":"2623_CR27","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1039\/D0CS01127D","volume":"50","author":"M Sousa de Almeida","year":"2021","unstructured":"Sousa de Almeida, M. et al. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem. Soc. Rev. 50, 5397\u20135434 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"2623_CR28","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1039\/D3BM00387F","volume":"11","author":"Q Zhong","year":"2023","unstructured":"Zhong, Q. et al. Structural and componential design: new strategies regulating the behavior of lipid-based nanoparticles in vivo. Biomater. Sci. 11, 4774\u20134788 (2023).","journal-title":"Biomater. Sci."},{"key":"2623_CR29","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1039\/D2TB00632D","volume":"10","author":"H Kong","year":"2022","unstructured":"Kong, H. et al. Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature. J. Mater. Chem. B 10, 6841\u20136858 (2022).","journal-title":"J. Mater. Chem. B"},{"key":"2623_CR30","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.accounts.5c00522","volume":"58","author":"H Yu","year":"2025","unstructured":"Yu, H., Dyett, B. P., Drummond, C. J. & Zhai, J. Ionizable lipid nanoparticles for mRNA delivery: internal self-assembled inverse mesophase structure and endosomal escape. Acc. Chem. Res. 58, 3210\u20133222 (2025).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","volume":"377","author":"B Binici","year":"2025","unstructured":"Binici, B., Rattray, Z., Zinger, A. & Perrie, Y. Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined in vitro and preclinical perspective. J. Control. Release 377, 162\u2013173 (2025).","journal-title":"J. Control. Release"},{"key":"2623_CR32","first-page":"101578","volume":"33","author":"Y He","year":"2025","unstructured":"He, Y. et al. Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated. Mol. Ther. 33, 101578 (2025).","journal-title":"Mol. Ther."},{"key":"2623_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301067120","volume":"120","author":"L Zheng","year":"2023","unstructured":"Zheng, L., Bandara, S. R., Tan, Z. & Leal, C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. Proc. Natl Acad. Sci. USA 120, e2301067120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR34","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1039\/D4NR00019F","volume":"16","author":"Y Wu","year":"2024","unstructured":"Wu, Y., Yu, S. & de L\u00e1zaro, I. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines. Nanoscale 16, 6820\u20136836 (2024).","journal-title":"Nanoscale"},{"key":"2623_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01153-6","volume":"10","author":"J Felgner","year":"2025","unstructured":"Felgner, J. et al. Lipid nanoparticle development for a fluvid mRNA vaccine targeting seasonal influenza and SARS-CoV-2. npj Vaccines 10, 123 (2025).","journal-title":"npj Vaccines"},{"key":"2623_CR36","doi-asserted-by":"publisher","first-page":"21968","DOI":"10.1039\/D2RA03761K","volume":"12","author":"J Desantis","year":"2022","unstructured":"Desantis, J. et al. PROTACs bearing piperazine-containing linkers: what effect on their protonation state? RSC Advances 12, 21968\u201321977 (2022).","journal-title":"RSC Advances"},{"key":"2623_CR37","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/14756366.2021.1931861","volume":"36","author":"R-H Zhang","year":"2021","unstructured":"Zhang, R.-H., Guo, H.-Y., Deng, H., Li, J. & Quan, Z.-S. Piperazine skeleton in the structural modification of natural products: a review. J. Enzyme Inhib. Med. Chem. 36, 1165\u20131197 (2021).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2623_CR38","doi-asserted-by":"crossref","unstructured":"Porte, S., V, V. & Sengupta, D. A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity. Small 21, e05404 (2025).","DOI":"10.1002\/smll.202505404"},{"key":"2623_CR39","doi-asserted-by":"publisher","first-page":"2300006","DOI":"10.1002\/anbr.202300006","volume":"3","author":"X Tang","year":"2023","unstructured":"Tang, X., Zhang, Y. & Han, X. Ionizable lipid nanoparticles for mRNA delivery. Adv. NanoBiomed. Res. 3, 2300006 (2023).","journal-title":"Adv. NanoBiomed. Res."},{"key":"2623_CR40","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","volume":"52","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R. & van der Meel, R. Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Acc. Chem. Res. 52, 2435\u20132444 (2019).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR41","doi-asserted-by":"publisher","first-page":"21733","DOI":"10.1039\/C9NR09347H","volume":"11","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni, J. A., Witzigmann, D., Leung, J., Tam, Y. Y. C. & Cullis, P. R. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale 11, 21733\u201321739 (2019).","journal-title":"Nanoscale"},{"key":"2623_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50093-7","volume":"15","author":"K Su","year":"2024","unstructured":"Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat. Commun. 15, 5659 (2024).","journal-title":"Nat. Commun."},{"key":"2623_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR44","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1021\/acs.biomac.3c00649","volume":"24","author":"P-o Khunsuk","year":"2023","unstructured":"Khunsuk, P. -o, Pongma, C., Palaga, T. & Hoven, V. P. Zwitterionic polymer-decorated lipid nanoparticles for mRNA delivery in mammalian cells. Biomacromolecules 24, 5654\u20135665 (2023).","journal-title":"Biomacromolecules"},{"key":"2623_CR45","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/acs.chemmater.3c00842","volume":"35","author":"S Li","year":"2023","unstructured":"Li, S., Wang, W. & Yu, X. A perspective of engineered lipids and liposomes: chemical design and functional application based on therapeutic safety. Chem. Mater. 35, 4587\u20134597 (2023).","journal-title":"Chem. Mater."},{"key":"2623_CR46","doi-asserted-by":"publisher","first-page":"114385","DOI":"10.1016\/j.ejpb.2024.114385","volume":"201","author":"M Mashal","year":"2024","unstructured":"Mashal, M. et al. Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery. Eur. J. Pharm. Biopharm. 201, 114385 (2024).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2623_CR47","unstructured":"Yu, M. et al. in Microfluidics in Pharmaceutical Sciences: Formulation, Drug Delivery, Screening, and Diagnostics (eds Lamprou, D. A. & Weaver, E.) 395\u2013420 (Springer Nature, 2024)."},{"key":"2623_CR48","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.matt.2022.03.006","volume":"5","author":"P Huang","year":"2022","unstructured":"Huang, P., Deng, H., Zhou, Y. & Chen, X. The roles of polymers in mRNA delivery. Matter 5, 1670\u20131699 (2022).","journal-title":"Matter"},{"key":"2623_CR49","doi-asserted-by":"publisher","first-page":"2202688","DOI":"10.1002\/adhm.202202688","volume":"12","author":"W Yang","year":"2023","unstructured":"Yang, W., Mixich, L., Boonstra, E. & Cabral, H. Polymer-based mRNA delivery strategies for advanced therapies. Adv. Healthc. Mater. 12, 2202688 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"2623_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41565-025-01961-w","volume":"20","author":"J Moreno Herrero","year":"2025","unstructured":"Moreno Herrero, J. et al. Compact polyethylenimine-complexed mRNA vaccines. Nat. Nanotechnol. 20, 1323\u20131331 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.actbio.2024.12.022","volume":"192","author":"S Yang","year":"2025","unstructured":"Yang, S. et al. Fluorinated polyethyleneimine vectors with serum resistance and adjuvant effect to deliver LMP2 mRNA vaccine for nasopharyngeal carcinoma therapy. Acta Biomater. 192, 340\u2013352 (2025).","journal-title":"Acta Biomater."},{"key":"2623_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nmat1645","volume":"5","author":"D Putnam","year":"2006","unstructured":"Putnam, D. Polymers for gene delivery across length scales. Nat. Mater. 5, 439\u2013451 (2006).","journal-title":"Nat. Mater."},{"key":"2623_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41570-018-0039-1","volume":"2","author":"I Lostal\u00e9-Seijo","year":"2018","unstructured":"Lostal\u00e9-Seijo, I. & Montenegro, J. Synthetic materials at the forefront of gene delivery. Nat. Rev. Chem. 2, 258\u2013277 (2018).","journal-title":"Nat. Rev. Chem."},{"key":"2623_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41467-017-00505-8","volume":"8","author":"HF Moffett","year":"2017","unstructured":"Moffett, H. F. et al. Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers. Nat. Commun. 8, 389 (2017).","journal-title":"Nat. Commun."},{"key":"2623_CR55","doi-asserted-by":"publisher","first-page":"E5859","DOI":"10.1073\/pnas.1805358115","volume":"115","author":"CJ McKinlay","year":"2018","unstructured":"McKinlay, C. J., Benner, N. L., Haabeth, O. A., Waymouth, R. M. & Wender, P. A. Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters. Proc. Natl Acad. Sci. USA 115, E5859\u2013E5866 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR56","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1021\/acs.accounts.8b00098","volume":"51","author":"M Vazdar","year":"2018","unstructured":"Vazdar, M. et al. Arginine \u201cmagic\u201d: guanidinium like-charge ion pairing from aqueous salts to cell penetrating peptides. Acc. Chem. Res. 51, 1455\u20131464 (2018).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR57","first-page":"2946","volume":"6","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. Functionalizing DNA nanostructures with natural cationic amino acids. Bioact. Mater. 6, 2946\u20132955 (2021).","journal-title":"Bioact. Mater."},{"key":"2623_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao, W. et al. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct. Target. Ther. 10, 74 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2623_CR59","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1039\/D5TB00766F","volume":"13","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Zhou, J., Su, R., Qi, W. & Wang, Y. Design of peptide-based gene delivery systems to overcome biological barriers. J. Mater. Chem. B 13, 12738\u201312764 (2025).","journal-title":"J. Mater. Chem. B"},{"key":"2623_CR60","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.apsb.2022.11.013","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. An mRNA vaccine elicits STING-dependent antitumor immune responses. Acta Pharm. Sin. B 13, 1274\u20131286 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2623_CR61","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/ar200256e","volume":"45","author":"I Nakase","year":"2012","unstructured":"Nakase, I. et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc. Chem. Res. 45, 1132\u20131139 (2012).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR62","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/nn800072t","volume":"2","author":"M Liong","year":"2008","unstructured":"Liong, M. et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, 889\u2013896 (2008).","journal-title":"ACS Nano"},{"key":"2623_CR63","doi-asserted-by":"publisher","first-page":"2005215","DOI":"10.1002\/adma.202005215","volume":"33","author":"Y Zou","year":"2021","unstructured":"Zou, Y., Huang, B., Cao, L., Deng, Y. & Su, J. Tailored mesoporous inorganic biomaterials: assembly, functionalization, and drug delivery engineering. Adv. Mater. 33, 2005215 (2021).","journal-title":"Adv. Mater."},{"key":"2623_CR64","doi-asserted-by":"publisher","first-page":"2308029","DOI":"10.1002\/adma.202308029","volume":"36","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Engineered mRNA delivery systems for biomedical applications. Adv. Mater. 36, 2308029 (2024).","journal-title":"Adv. Mater."},{"key":"2623_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat. Biomed. Eng. 4, 69\u201383 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR66","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"2623_CR67","doi-asserted-by":"publisher","first-page":"100240","DOI":"10.1016\/j.mtadv.2022.100240","volume":"14","author":"RA Meyer","year":"2022","unstructured":"Meyer, R. A., Neshat, S. Y., Green, J. J., Santos, J. L. & Tuesca, A. D. Targeting strategies for mRNA delivery. Mater Today Adv. 14, 100240 (2022).","journal-title":"Mater Today Adv."},{"key":"2623_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20903-3","volume":"12","author":"F Rizvi","year":"2021","unstructured":"Rizvi, F. et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nat. Commun. 12, 613 (2021).","journal-title":"Nat. Commun."},{"key":"2623_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","volume":"55","author":"D Loughrey","year":"2022","unstructured":"Loughrey, D. & Dahlman, J. E. Non-liver mRNA delivery. Acc. Chem. Res. 55, 13\u201323 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116271119","volume":"119","author":"M Qiu","year":"2022","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR71","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","volume":"3","author":"KE Lindsay","year":"2019","unstructured":"Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371\u2013380 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR72","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","volume":"17","author":"MA Oberli","year":"2016","unstructured":"Oberli, M. A. et al. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett. 17, 1326\u20131335 (2016).","journal-title":"Nano Lett."},{"key":"2623_CR73","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/acs.nanolett.0c05039","volume":"21","author":"Y Yin","year":"2021","unstructured":"Yin, Y. et al. Transforming RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for durable cancer immunotherapy. Nano Lett. 21, 2224\u20132231 (2021).","journal-title":"Nano Lett."},{"key":"2623_CR74","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis, D., Jacquinet, E., Rogers, M. A. & Amiji, M. M. Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat. Rev. Drug Discov. 23, 281\u2013300 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2623_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23546-6","volume":"12","author":"D Sz\u0151ke","year":"2021","unstructured":"Sz\u0151ke, D. et al. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema. Nat. Commun. 12, 3460 (2021).","journal-title":"Nat. Commun."},{"key":"2623_CR76","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1021\/acs.accounts.1c00493","volume":"54","author":"M Qin","year":"2021","unstructured":"Qin, M., Du, G. S. & Sun, X. Recent advances in the noninvasive delivery of mRNA. Acc. Chem. Res. 54, 4262\u20134271 (2021).","journal-title":"Acc. Chem. Res."},{"key":"2623_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7804","volume":"13","author":"C Hotz","year":"2021","unstructured":"Hotz, C. et al. Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models. Sci. Transl. Med. 13, eabc7804 (2021).","journal-title":"Sci. Transl. Med."},{"key":"2623_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805116","volume":"31","author":"AK Patel","year":"2019","unstructured":"Patel, A. K. et al. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium. Adv. Mater. 31, e1805116 (2019).","journal-title":"Adv. Mater."},{"key":"2623_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102610","volume":"11","author":"S Zha","year":"2022","unstructured":"Zha, S., Wong, K. L. & All, A. H. Intranasal delivery of functionalized polymeric nanomaterials to the brain. Adv. Healthc. Mater. 11, e2102610 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"2623_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202303713","volume":"19","author":"CH Bai","year":"2023","unstructured":"Bai, C. H., Wang, C. & Lu, Y. Novel vectors and administrations for mRNA delivery. Small 19, e2303713 (2023).","journal-title":"Small"},{"key":"2623_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121707","volume":"288","author":"JS Sung","year":"2022","unstructured":"Sung, J. S., Alghoul, Z., Long, D. P., Yang, C. H. & Merlin, D. Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: a novel therapeutic solution to treat ulcerative colitis. Biomaterials 288, e2307796121 (2022).","journal-title":"Biomaterials"},{"key":"2623_CR82","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.matt.2021.12.022","volume":"5","author":"A Abramson","year":"2022","unstructured":"Abramson, A. et al. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter 5, 975\u2013987 (2022).","journal-title":"Matter"},{"key":"2623_CR83","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jconrel.2019.06.042","volume":"307","author":"J Devoldere","year":"2019","unstructured":"Devoldere, J. et al. Non-viral delivery of chemically modified mRNA to the retina: subretinal intravitreal administration. J. Control. Release 307, 315\u2013330 (2019).","journal-title":"J. Control. Release"},{"key":"2623_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/srep20019","volume":"6","author":"JF Nabhan","year":"2016","unstructured":"Nabhan, J. F. et al. Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich\u2019s ataxia. Sci. Rep. 6, 20019 (2016).","journal-title":"Sci. Rep."},{"key":"2623_CR85","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","volume":"31","author":"V Anttila","year":"2023","unstructured":"Anttila, V. et al. Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting. Mol. Ther. 31, 866\u2013874 (2023).","journal-title":"Mol. Ther."},{"key":"2623_CR86","first-page":"387","volume":"25","author":"KW Gao","year":"2023","unstructured":"Gao, K. W. et al. In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles. Bioact. Mater. 25, 387\u2013398 (2023).","journal-title":"Bioact. Mater."},{"key":"2623_CR87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112696119","volume":"119","author":"N Kong","year":"2022","unstructured":"Kong, N. et al. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc. Natl Acad. Sci. USA 119, e2112696119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR88","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon, E., Ad-El, N., Hazan-Halevy, I., Stotsky-Oterin, L. & Peer, D. Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects. Nat. Rev. Clin. Oncol. 20, 739\u2013754 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2623_CR89","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.7150\/thno.87316","volume":"13","author":"L Lin","year":"2023","unstructured":"Lin, L., Su, K., Cheng, Q. & Liu, S. Targeting materials and strategies for RNA delivery. Theranostics 13, 4667\u20134693 (2023).","journal-title":"Theranostics"},{"key":"2623_CR90","doi-asserted-by":"publisher","first-page":"e2307796121","DOI":"10.1073\/pnas.2307796121","volume":"121","author":"CA Tsuchida","year":"2024","unstructured":"Tsuchida, C. A., Wasko, K. M., Hamilton, J. R. & Doudna, J. A. Targeted nonviral delivery of genome editors in vivo. Proc. Natl Acad. Sci. USA 121, e2307796121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR91","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1002\/anie.202008082","volume":"59","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. Imidazole-based synthetic lipidoids for in vivo mRNA delivery into primary T lymphocytes. Angew. Chem. Int. Ed. 59, 20083\u201320089 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2623_CR92","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","volume":"5","author":"MP Lokugamage","year":"2021","unstructured":"Lokugamage, M. P. et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat. Biomed. Eng. 5, 1059\u20131068 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR93","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","volume":"3","author":"SS Nogueira","year":"2020","unstructured":"Nogueira, S. S. et al. Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery. ACS Appl. Nano Mater. 3, 10634\u201310645 (2020).","journal-title":"ACS Appl. Nano Mater."},{"key":"2623_CR94","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1039\/D2CS00998F","volume":"52","author":"L Fu","year":"2023","unstructured":"Fu, L. et al. \u2018Passive\u2019 nanoparticles for organ-selective systemic delivery: design, mechanism and perspective. Chem. Soc. Rev. 52, 7579\u20137601 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"2623_CR95","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1021\/acs.nanolett.8b02917","volume":"18","author":"JC Kaczmarek","year":"2018","unstructured":"Kaczmarek, J. C. et al. Optimization of a degradable polymer\u2013lipid nanoparticle for potent systemic delivery of mRNA to the lung endothelium and immune cells. Nano Lett. 18, 6449\u20136454 (2018).","journal-title":"Nano Lett."},{"key":"2623_CR96","doi-asserted-by":"publisher","first-page":"1902604","DOI":"10.1002\/adma.201902604","volume":"32","author":"P Mi","year":"2020","unstructured":"Mi, P., Cabral, H. & Kataoka, K. Ligand-installed nanocarriers toward precision therapy. Adv. Mater. 32, 1902604 (2020).","journal-title":"Adv. Mater."},{"key":"2623_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"2623_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead, K. A., Langer, R. & Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129\u2013138 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2623_CR99","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396\u2013401 (2016).","journal-title":"Nature"},{"key":"2623_CR100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307801120","volume":"121","author":"A Radmand","year":"2024","unstructured":"Radmand, A. et al. Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart. Proc. Natl Acad. Sci. USA 121, e2307801120 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR102","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.adk9428","volume":"384","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. In vivo editing of lung stem cells for durable gene correction in mice. Science 384, 1196\u20131202 (2024).","journal-title":"Science"},{"key":"2623_CR103","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"2623_CR104","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","volume":"29","author":"I Tomb\u00e1cz","year":"2021","unstructured":"Tomb\u00e1cz, I. et al. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Mol. Ther. 29, 3293\u20133304 (2021).","journal-title":"Mol. Ther."},{"key":"2623_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06936-1","volume":"9","author":"N Veiga","year":"2018","unstructured":"Veiga, N. et al. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nat. Commun. 9, 4493 (2018).","journal-title":"Nat. Commun."},{"key":"2623_CR106","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 2938\u20132944 (2023).","journal-title":"Nano Lett."},{"key":"2623_CR107","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","volume":"291","author":"H Parhiz","year":"2018","unstructured":"Parhiz, H. et al. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. J. Control. Release 291, 106\u2013115 (2018).","journal-title":"J. Control. Release"},{"key":"2623_CR108","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1073\/pnas.1912012117","volume":"117","author":"OA Marcos-Contreras","year":"2020","unstructured":"Marcos-Contreras, O. A. et al. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood\u2013brain barrier. Proc. Natl Acad. Sci. USA 117, 3405\u20133414 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR109","doi-asserted-by":"publisher","first-page":"2204342","DOI":"10.1002\/adfm.202204342","volume":"32","author":"S Lei","year":"2022","unstructured":"Lei, S. et al. ALPPL2-binding peptide facilitates targeted mRNA delivery for efficient hepatocellular carcinoma gene therapy. Adv. Funct. Mater. 32, 2204342 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"2623_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37020-y","volume":"14","author":"M Hu","year":"2023","unstructured":"Hu, M. et al. Lantern-shaped flexible RNA origami for Smad4 mRNA delivery and growth suppression of colorectal cancer. Nat. Commun. 14, 1307 (2023).","journal-title":"Nat. Commun."},{"key":"2623_CR111","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.omtn.2020.06.013","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Therapeutic effects of simultaneous delivery of nerve growth factor mRNA and protein via exosomes on cerebral ischemia. Mol. Ther. Nucleic Acids 21, 512\u2013522 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2623_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11911-5","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat. Commun. 10, 3974 (2019).","journal-title":"Nat. Commun."},{"key":"2623_CR113","doi-asserted-by":"publisher","first-page":"1900849","DOI":"10.1002\/adhm.201900849","volume":"8","author":"C Fornaguera","year":"2019","unstructured":"Fornaguera, C. et al. In vivo retargeting of poly(beta aminoester) (OM-PBAE) nanoparticles is influenced by protein corona. Adv. Healthc. Mater. 8, 1900849 (2019).","journal-title":"Adv. Healthc. Mater."},{"key":"2623_CR114","doi-asserted-by":"publisher","first-page":"46585","DOI":"10.1021\/acsami.9b17749","volume":"11","author":"Q Tang","year":"2019","unstructured":"Tang, Q. et al. Cell-selective messenger RNA delivery and CRISPR\/Cas9 genome editing by modulating the interface of phenylboronic acid-derived lipid nanoparticles and cellular surface sialic acid. ACS Appl. Mater. Interfaces 11, 46585\u201346590 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2623_CR115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jconrel.2023.11.008","volume":"364","author":"X Tang","year":"2023","unstructured":"Tang, X. et al. Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects. J. Control. Release 364, 529\u2013545 (2023).","journal-title":"J. Control. Release"},{"key":"2623_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33\u201348 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2623_CR117","doi-asserted-by":"publisher","first-page":"2300935","DOI":"10.1002\/adhm.202300935","volume":"12","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Black phosphorus nanosheets assist nanoerythrosomes for efficient mRNA vaccine delivery and immune activation. Adv. Healthc. Mater. 12, 2300935 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"2623_CR118","doi-asserted-by":"publisher","first-page":"2302423","DOI":"10.1002\/advs.202302423","volume":"10","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Dendritic cell-mimicking nanoparticles promote mRNA delivery to lymphoid organs. Adv. Sci. 10, 2302423 (2023).","journal-title":"Adv. Sci."},{"key":"2623_CR119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41551-023-01150-x","volume":"8","author":"W Gu","year":"2024","unstructured":"Gu, W. et al. Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA into neurons. Nat. Biomed. Eng. 8, 415\u2013426 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42365-5","volume":"14","author":"S Dong","year":"2023","unstructured":"Dong, S. et al. Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer. Nat. Commun. 14, 6610 (2023).","journal-title":"Nat. Commun."},{"key":"2623_CR121","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202204031","volume":"19","author":"Y Xing","year":"2023","unstructured":"Xing, Y. et al. Efficient delivery of GSDMD-N mRNA by engineered extracellular vesicles induces pyroptosis for enhanced immunotherapy. Small 19, 2204031 (2023).","journal-title":"Small"},{"key":"2623_CR122","doi-asserted-by":"publisher","first-page":"2109984","DOI":"10.1002\/adma.202109984","volume":"34","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Rapid surface display of mRNA antigens by bacteria-derived outer membrane vesicles for a personalized tumor vaccine. Adv. Mater. 34, 2109984 (2022).","journal-title":"Adv. Mater."},{"key":"2623_CR123","doi-asserted-by":"publisher","first-page":"2303597","DOI":"10.1002\/advs.202303597","volume":"10","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. Stimuli-responsive nanotechnology for RNA delivery. Adv. Sci. 10, 2303597 (2023).","journal-title":"Adv. Sci."},{"key":"2623_CR124","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"2623_CR125","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","volume":"19","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nat. Nanotechnol. 19, 1702\u20131711 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR126","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41578-023-00617-2","volume":"9","author":"L Xue","year":"2023","unstructured":"Xue, L. et al. Responsive biomaterials: optimizing control of cancer immunotherapy. Nat. Rev. Mater. 9, 100\u2013118 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"2623_CR127","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1039\/D3TB01311A","volume":"11","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. An ultra pH-responsive peptide nanocarrier for cancer gene therapy. J Mater. Chem. B 11, 8974\u20138984 (2023).","journal-title":"J Mater. Chem. B"},{"key":"2623_CR128","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13045-022-01320-5","volume":"15","author":"H Tian","year":"2022","unstructured":"Tian, H. et al. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. J. Hematol. Oncol. 15, 132 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2623_CR129","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1021\/acscentsci.0c01648","volume":"7","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Rational design of poly(disulfide)s as a universal platform for delivery of CRISPR\u2013Cas9 machineries toward therapeutic genome editing. ACS Cent. Sci. 7, 990\u20131000 (2021).","journal-title":"ACS Cent. Sci."},{"key":"2623_CR130","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322935121","volume":"121","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Accelerating diabetic wound healing by ROS-scavenging lipid nanoparticle\u2013mRNA formulation. Proc. Natl Acad. Sci. USA 121, e2322935121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR131","doi-asserted-by":"publisher","first-page":"2204947","DOI":"10.1002\/adfm.202204947","volume":"32","author":"W Cai","year":"2022","unstructured":"Cai, W., Luo, T., Chen, X., Mao, L. & Wang, M. A combinatorial library of biodegradable lipid nanoparticles preferentially deliver mRNA into tumor cells to block mutant RAS signaling. Adv. Funct. Mater. 32, 2204947 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"2623_CR132","doi-asserted-by":"publisher","first-page":"2300502","DOI":"10.1002\/advs.202300502","volume":"10","author":"YF Zhao","year":"2023","unstructured":"Zhao, Y. F. et al. CES1-triggered liver-specific cargo release of CRISPR\/Cas9 elements by cationic triadic copolymeric nanoparticles targeting gene editing of PCSK9 for hyperlipidemia amelioration. Adv. Sci. 10, 2300502 (2023).","journal-title":"Adv. Sci."},{"key":"2623_CR133","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jconrel.2020.12.033","volume":"330","author":"N Yoshinaga","year":"2021","unstructured":"Yoshinaga, N. et al. mRNA loading into ATP-responsive polyplex micelles with optimal density of phenylboronate ester crosslinking to balance robustness in the biological milieu and intracellular translational efficiency. J. Control. Release 330, 317\u2013328 (2021).","journal-title":"J. Control. Release"},{"key":"2623_CR134","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","volume":"348","author":"K Ogawa","year":"2022","unstructured":"Ogawa, K. et al. Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J. Control. Release 348, 34\u201341 (2022).","journal-title":"J. Control. Release"},{"key":"2623_CR135","doi-asserted-by":"publisher","first-page":"24139","DOI":"10.1021\/acsnano.4c05270","volume":"18","author":"G Kwak","year":"2024","unstructured":"Kwak, G. et al. Brain nucleic acid delivery and genome editing via focused ultrasound-mediated blood\u2013brain barrier opening and long-circulating nanoparticles. ACS Nano 18, 24139\u201324153 (2024).","journal-title":"ACS Nano"},{"key":"2623_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01145-3","volume":"19","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Ultrasound triggered topical delivery of Bmp7 mRNA for white fat browning induction via engineered smart exosomes. J. Nanobiotechnol. 19, 402 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"2623_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202302676","volume":"62","author":"B Li","year":"2023","unstructured":"Li, B. et al. Activatable NIR-II photothermal lipid nanoparticles for improved messenger RNA delivery. Angew. Chem. Int. Ed. 62, e202302676 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2623_CR138","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41557-021-00854-4","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Phase-separating peptides for direct cytosolic delivery and redox-activated release of macromolecular therapeutics. Nat. Chem. 14, 274\u2013283 (2022).","journal-title":"Nat. Chem."},{"key":"2623_CR139","doi-asserted-by":"publisher","first-page":"2204905","DOI":"10.1002\/advs.202204905","volume":"10","author":"F Li","year":"2023","unstructured":"Li, F. et al. A thermal and enzymatic dual-stimuli responsive DNA-based nanomachine for controlled mRNA delivery. Adv. Sci. 10, 2204905 (2023).","journal-title":"Adv. Sci."},{"key":"2623_CR140","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","volume":"21","author":"EJ Sayour","year":"2024","unstructured":"Sayour, E. J., Boczkowski, D., Mitchell, D. A. & Nair, S. K. Cancer mRNA vaccines: clinical advances and future opportunities. Nat. Rev. Clin. Oncol. 21, 489\u2013500 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2623_CR141","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2024.08.018","volume":"374","author":"C Garc\u00ed\u00ada-Fern\u00e1\u00a1ndez","year":"2024","unstructured":"Garc\u00ed\u00ada-Fern\u00e1\u00a1ndez, C. et al. Stealth mRNA nanovaccines to control lymph node trafficking. J. Control. Release 374, 325\u2013336 (2024).","journal-title":"J. Control. Release"},{"key":"2623_CR142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207841119","volume":"119","author":"JJ Chen","year":"2022","unstructured":"Chen, J. J. et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8 T cell response. Proc. Natl Acad. Sci. USA 119, e2207841119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR143","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","volume":"26","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer. Mol. Ther. 26, 45\u201355 (2018).","journal-title":"Mol. Ther."},{"key":"2623_CR144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301606120","volume":"120","author":"E Ben-Akiva","year":"2023","unstructured":"Ben-Akiva, E. et al. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination. Proc. Natl Acad. Sci. USA 120, e2301606120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR145","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","volume":"371","author":"C Krienke","year":"2021","unstructured":"Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145\u2013153 (2021).","journal-title":"Science"},{"key":"2623_CR146","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","volume":"9","author":"D Yin","year":"2024","unstructured":"Yin, D. et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat. Biomed. Eng. 9, 185\u2013200 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318515","volume":"63","author":"JQ Lei","year":"2024","unstructured":"Lei, J. Q. et al. Development of mannosylated lipid nanoparticles for mRNA cancer vaccine with high antigen presentation efficiency and immunomodulatory capability. Angew. Chem. Int. Ed. 63, e202318515 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2623_CR148","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/psp4.12301","volume":"7","author":"JF Apgar","year":"2018","unstructured":"Apgar, J. F. et al. Quantitative systems pharmacology model of hUGT1A1-modRNA encoding for the UGT1A1 enzyme to treat Crigler\u2013Najjar syndrome type 1. CPT Pharmacometrics Syst. Pharmacol. 7, 404\u2013412 (2018).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"2623_CR149","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ymthe.2017.12.024","volume":"26","author":"MG Prieve","year":"2018","unstructured":"Prieve, M. G. et al. Targeted mRNA therapy for ornithine transcarbamylase deficiency. Mol. Ther. 26, 801\u2013813 (2018).","journal-title":"Mol. Ther."},{"key":"2623_CR150","doi-asserted-by":"publisher","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","volume":"114","author":"S Ramaswamy","year":"2017","unstructured":"Ramaswamy, S. et al. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc. Natl Acad. Sci. USA 114, E1941\u2013E1950 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2623_CR151","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ebiom.2019.07.003","volume":"45","author":"D An","year":"2019","unstructured":"An, D. et al. Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia. eBioMedicine 45, 519\u2013528 (2019).","journal-title":"eBioMedicine"},{"key":"2623_CR152","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jconrel.2024.03.056","volume":"369","author":"G Shen","year":"2024","unstructured":"Shen, G., Liu, J., Yang, H., Xie, N. & Yang, Y. mRNA therapies: pioneering a new era in rare genetic disease treatment. J. Control. Release 369, 696\u2013721 (2024).","journal-title":"J. Control. Release"},{"key":"2623_CR153","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","volume":"22","author":"SM Rowe","year":"2023","unstructured":"Rowe, S. M. et al. Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study. J. Cyst. Fibros. 22, 656\u2013664 (2023).","journal-title":"J. Cyst. Fibros."},{"key":"2623_CR154","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.pupt.2022.102134","volume":"75","author":"CJ Woo","year":"2022","unstructured":"Woo, C. J. et al. Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia. Pulm. Pharmacol. Ther. 75, 102134 (2022).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2623_CR155","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.omtm.2020.05.030","volume":"18","author":"V Anttila","year":"2020","unstructured":"Anttila, V. et al. Synthetic mRNA encoding VEGF-A in patients undergoing coronary artery bypass grafting: design of a Phase 2a clinical trial. Mol. Ther. Methods Clin. Dev. 18, 464\u2013472 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2623_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120681","volume":"270","author":"Y Fukushima","year":"2021","unstructured":"Fukushima, Y. et al. Treatment of ischemic neuronal death by introducing brain-derived neurotrophic factor mRNA using polyplex nanomicelle. Biomaterials 270, 120681 (2021).","journal-title":"Biomaterials"},{"key":"2623_CR157","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41551-022-00989-w","volume":"7","author":"Y You","year":"2023","unstructured":"You, Y. et al. Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy. Nat. Biomed. Eng. 7, 887\u2013900 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"2623_CR158","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1021\/acsnano.0c04707","volume":"14","author":"T Wei","year":"2020","unstructured":"Wei, T. et al. Delivery of tissue-targeted scalpels: opportunities and challenges for in vivo CRISPR\/Cas-based genome editing. ACS Nano 14, 9243\u20139262 (2020).","journal-title":"ACS Nano"},{"key":"2623_CR159","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR\u2013Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2623_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37465-1","volume":"14","author":"LN Kasiewicz","year":"2023","unstructured":"Kasiewicz, L. N. et al. GalNAc-lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy. Nat. Commun. 14, 2776 (2023).","journal-title":"Nat. Commun."},{"key":"2623_CR161","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1089\/hum.2020.137","volume":"31","author":"A Da Silva Sanchez","year":"2020","unstructured":"Da Silva Sanchez, A., Paunovska, K., Cristian, A. & Dahlman, J. E. Treating cystic fibrosis with mRNA and CRISPR. Hum. Gene Ther. 31, 940\u2013955 (2020).","journal-title":"Hum. Gene Ther."},{"key":"2623_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42948-2","volume":"14","author":"T Wei","year":"2023","unstructured":"Wei, T. et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models. Nat. Commun. 14, 7322 (2023).","journal-title":"Nat. Commun."},{"key":"2623_CR163","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc9450","volume":"6","author":"D Rosenblum","year":"2020","unstructured":"Rosenblum, D. et al. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Sci Adv 6, eabc9450 (2020).","journal-title":"Sci Adv"},{"key":"2623_CR164","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","volume":"39","author":"D Yin","year":"2021","unstructured":"Yin, D. et al. Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice. Nat. Biotechnol. 39, 567\u2013577 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2623_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26714-w","volume":"12","author":"E Kenjo","year":"2021","unstructured":"Kenjo, E. et al. Low immunogenicity of LNP allows repeated administrations of CRISPR\u2013Cas9 mRNA into skeletal muscle in mice. Nat. Commun. 12, 7101 (2021).","journal-title":"Nat. Commun."},{"key":"2623_CR166","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. 19, 1409\u20131417 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2623_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50619-z","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02623-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:02:44Z","timestamp":1794333764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41563-026-02623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":167,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1038\/s41563-026-02623-5","relation":{},"ISSN":["1476-1122","1476-4660"],"issn-type":[{"value":"1476-1122","type":"print"},{"value":"1476-4660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}